Studies on the Terminal Stages of Immune Hemolysis. VI. Osmotic Blockers of Differing Stokes' Radii Detect Commplement-Induced Transmembrane Channels of Differing Size

Abstract

In “Studies on the Terminal Stages of Immune Hemolysis. VI. Osmotic Blockers of Differing Stokes' Radii Detect Complement-Induced Transmembrane Channels of Differing Size” by Michael D. P. Boyle, Adrian P. Gee, and Tibor Borsos in the July 1979 issue of the Journal of Immunology, Volume 123, No. 1, page 81, a line in the Discussion was inadvertently omitted. The sentence starting four lines below the end of the legend to Figure 6 should read:

“If this were the case, 0.1 M EDTA should prevent the release of hemoglobin from E treated with the channel-forming drugs nystatin [forming a channel of radius 2–3 Å (8–10)], amphotericin B [forming a channel of radius 3.5–5 Å (8–10)] but not from E treated with filipin [forming a channel of radius 40–50 Å (11)].”